Joel Greenblatt Tg Therapeutics, Inc. Transaction History

Gotham Asset Management, LLC

$11.5 Billion
Q1 2025

A detailed history of Joel Greenblatt (Gotham Asset Management, LLC) transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Gotham Asset Management, LLC holds 46,735 shares of TGTX stock, worth $1.25 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

46,735

Previous 50,949 8.27%

Holding current value

$1.25 Million

Previous $1.53 Million 20.16%

% of portfolio

0.02%

Previous 0.02%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$27.67 - $42.99 $116,601 - $181,159	-4,214 Reduced 8.27%	46,735 $1.84 Million
Q4 2024 Feb 14, 2025	SELL	$21.31 - $35.09 $1.37 Million - $2.26 Million	-64,333 Reduced 55.8%	50,949 $1.53 Million
Q3 2024 Nov 14, 2024	BUY	$17.21 - $25.28 $722,389 - $1.06 Million	41,975 Added 57.26%	115,282 $2.7 Million
Q2 2024 Aug 14, 2024	BUY	$13.32 - $19.19 $23,056 - $33,217	1,731 Added 2.42%	73,307 $1.3 Million
Q1 2024 May 15, 2024	SELL	$13.02 - $21.3 $321,255 - $525,556	-24,674 Reduced 25.64%	71,576 $1.09 Million
Q4 2023 Feb 14, 2024	BUY	$6.68 - $18.81 $165,844 - $466,995	24,827 Added 34.76%	96,250 $1.64 Million
Q3 2023 Nov 14, 2023	SELL	$8.36 - $26.5 $495,505 - $1.57 Million	-59,271 Reduced 45.35%	71,423 $597,000
Q2 2023 Aug 14, 2023	BUY	$15.48 - $35.0 $151,812 - $343,245	9,807 Added 8.11%	130,694 $3.25 Million
Q1 2023 May 15, 2023	SELL	$10.23 - $19.34 $56,827 - $107,433	-5,555 Reduced 4.39%	120,887 $1.82 Million
Q4 2022 Feb 14, 2023	BUY	$5.01 - $11.83 $633,474 - $1.5 Million	126,442 New	126,442 $1.5 Million
Q2 2021 Aug 16, 2021	SELL	$32.5 - $48.96 $349,570 - $526,613	-10,756 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$41.61 - $54.3 $955,365 - $1.25 Million	-22,960 Reduced 68.1%	10,756 $518,000
Q4 2020 Feb 16, 2021	BUY	$25.27 - $54.9 $404 - $878	16 Added 0.05%	33,716 $1.75 Million
Q3 2020 Nov 16, 2020	SELL	$18.49 - $27.24 $205,017 - $302,037	-11,088 Reduced 24.76%	33,700 $902,000
Q2 2020 Aug 13, 2020	BUY	$8.9 - $21.84 $398,613 - $978,169	44,788 New	44,788 $872,000
Q4 2019 Feb 14, 2020	SELL	$5.1 - $11.2 $56,635 - $124,375	-11,105 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$5.38 - $8.99 $59,744 - $99,833	11,105 New	11,105 $62,000

Others Institutions Holding TGTX

# of Institutions

415

Shares Held

88.5M

Call Options Held

2.34M

Put Options Held

1.93M

View Full List

About TG THERAPEUTICS, INC.

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $3.88B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

More about TGTX

Track Joel Greenblatt's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gotham Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gotham Asset Management, LLC and Joel Greenblatt with notifications on news.

Account